MedTrace Logo

Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC

NCT07500259 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 188

Last updated 2026-03-30

No results posted yet for this study

Summary

The ColoPan study evaluates the scientific validity, reproducibility, and predictive performance of the Personalised Functional Profiling (PFP) platform in colorectal cancer and pancreatic ductal adenocarcinoma patients. It combines genomic sequencing with in vitro functional drug testing using patient-derived spheroids/organoids.

Conditions

Interventions

OTHER

Personalized Functional Profiling

This is an observational study where biological samples are collected to provide Personalized Functional Profiling, an integrated strategy that combines genomic analysis with direct drug response assessments using patient-derived spheroids/organoids (PDSOs)

Sponsors & Collaborators

  • Hopitaux Robert Schuman

    collaborator UNKNOWN

  • Luxembourg Institute of Health

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2029-09-30
Completion
2034-11-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07500259 on ClinicalTrials.gov